SSH - MIAMI — History
CCN 102001 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$26M
Latest Revenue (FY2022)
-3.6%
Revenue CAGR (3yr)
8.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $29M | $26M | -9.1% | -3.6% |
| Operating Expenses | $24M | $26M | $24M | -7.7% | -0.8% |
| Operating Margin | 13.2% | 9.5% | 8.1% | -14.3% | -21.7% |
| Net Income | $4M | $3M | $2M | -22.1% | -24.5% |
| Licensed Beds | 47 | 47 | 47 | +0.0% | +0.0% |
| Total Patient Days | 15,512 | 15,935 | 14,040 | -11.9% | -4.9% |
| Medicare Day % | 36% | 45% | 50% | +9.1% | +17.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -7.0% ($28M → $26M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-3.6%
This Hospital
+7.6%
State Avg
Latest Margin
8.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $25M | 5.5% |
| FY2024 (proj) | $24M | 3.0% |
| FY2025 (proj) | $23M | 0.4% |